Stem cells in triple negative breast cancer and associated in situ lesions

被引：0
|
作者：
Comanescu, M. [1 ]
Dobre, M. [1 ]
Bussolati, G. [1 ]
机构：
[1] Victor Babes Inst, Dept Pathol, R-76201 Bucharest, Romania
来源：
VIRCHOWS ARCHIV | 2012年 / 461卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] Combination of docetaxel with sulforaphane synergistically inhibits triple negative breast cancer and cancer stem cells
    Burnett, Joseph P.
    Shah, Ronack B.
    Paholak, Hayley J.
    McDermott, Sean P.
    Tsume, Yasuhiro
    Wicha, Max W.
    Sun, Duxin
    CANCER RESEARCH, 2015, 75
  • [22] Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
    O'Conor, Christopher J.
    Chen, Tiffany
    Gonzalez, Ivan
    Cao, Dengfeng
    Peng, Yan
    BIOMARKERS IN MEDICINE, 2018, 12 (07) : 813 - 820
  • [23] Vaccine targeting antigens associated with cancer stem cells/epithelial to mesenchymal transition inhibits triple negative breast cancer growth
    Cecil, Denise L.
    Curtis, Benjamin
    Gad, Ekram
    Corulli, Lauren
    Disis, Mary L.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [24] Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
    Lin, Chang-Ching
    Lo, Miao-Chia
    Moody, Rebecca
    Jiang, Hui
    Harouaka, Ramdane
    Stevers, Nicholas
    Tinsley, Samantha
    Gasparyan, Mari
    Wicha, Max
    Sun, Duxin
    CANCER LETTERS, 2018, 438 : 165 - 173
  • [25] Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
    Tanei, Tomonori
    Choi, Dong Soon
    Rodriguez, Angel A.
    Liang, Diana Hwang
    Dobrolecki, Lacey
    Ghosh, Madhumita
    Landis, Melissa D.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2016, 18
  • [26] Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
    Tomonori Tanei
    Dong Soon Choi
    Angel A. Rodriguez
    Diana Hwang Liang
    Lacey Dobrolecki
    Madhumita Ghosh
    Melissa D. Landis
    Jenny C. Chang
    Breast Cancer Research, 18
  • [27] Phenotypic and genotypic analysis of triple negative breast cancer with an emphasis on the identification of stem cells
    Comanescu, M.
    Ivan, R.
    Bussolati, G.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 102 - 102
  • [28] Development of novel in situ immunotherapy for triple negative breast cancer
    Oba, Takaaki
    Ito, Fumito
    Ito, Kenichi
    CANCER SCIENCE, 2025, 116 : 27 - 27
  • [29] GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
    Khoa Nguyen
    McConnell, Emily
    Edwards, Orielle
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    CANCER DRUG RESISTANCE, 2022, 5 (03) : 721 - 726
  • [30] Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
    Yang, Fang
    Cao, Lulu
    Sun, Zijia
    Jin, Juan
    Fang, Hehui
    Zhang, Wenwen
    Guan, Xiaoxiang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (12): : 1568 - 1577
12345